A phase II study evaluating the toxicity and efficacy of single-agent temsirolimus in chemotherapy-naïve castration-resistant prostate cancer.

Autor: Kruczek, K1, Ratterman, M1, Tolzien, K2, Sulo, S3, Lestingi, T M2, Nabhan, C4
Zdroj: British Journal of Cancer. 10/1/2013, Vol. 109 Issue 7, p1711-1716. 6p.
Databáze: Academic Search Ultimate